User profiles for M. Loeffler
Markus Loeffler OR Markus LöfflerInstitute for Medical Informatics, Statistics and Epidemiology Verified email at imise.uni-leipzig.de Cited by 62567 |
Stem cells: attributes, cycles, spirals, pitfalls and uncertainties lessons for and from the crypt
CS Potten, M Loeffler - Development, 1990 - journals.biologists.com
We consider some of the problems involved in current discussions on stem cells in adult
mammalian tissues. The present concepts involve a number of pitfalls, weaknesses and logical, …
mammalian tissues. The present concepts involve a number of pitfalls, weaknesses and logical, …
Apoptosis‐inducing factor (AIF): a ubiquitous mitochondrial oxidoreductase involved in apoptosis
E Daugas, D Nochy, L Ravagnan, M Loeffler… - FEBS …, 2000 - Wiley Online Library
Apoptosis‐inducing factor (AIF) is encoded by one single gene located on the X chromosome.
AIF is ubiquitously expressed, both in normal tissues and in a variety of cancer cell lines. …
AIF is ubiquitously expressed, both in normal tissues and in a variety of cancer cell lines. …
The mitochondrion in cell death control: certainties and incognita
M Loeffler, G Kroemer - Experimental cell research, 2000 - Elsevier
Apoptosis research has recently experienced a change from a paradigm in which the nucleus
determined the apoptotic process to a paradigm in which caspases and, more recently, …
determined the apoptotic process to a paradigm in which caspases and, more recently, …
Molecular characterization of mitochondrial apoptosis-inducing factor
…, J Mangion, E Jacotot, P Costantini, M Loeffler… - Nature, 1999 - nature.com
Mitochondria play a key part in the regulation of apoptosis (cell death) 1 , 2 . Their
intermembrane space contains several proteins that are liberated through the outer membrane in …
intermembrane space contains several proteins that are liberated through the outer membrane in …
[HTML][HTML] Intensive insulin therapy and pentastarch resuscitation in severe sepsis
…, C Hartog, C Natanson, M Loeffler… - … England Journal of …, 2008 - Mass Medical Soc
Background The role of intensive insulin therapy in patients with severe sepsis is uncertain.
Fluid resuscitation improves survival among patients with septic shock, but evidence is …
Fluid resuscitation improves survival among patients with septic shock, but evidence is …
Large-scale cis- and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression
Trait-associated genetic variants affect complex phenotypes primarily via regulatory mechanisms
on the transcriptome. To investigate the genetics of gene expression, we performed cis…
on the transcriptome. To investigate the genetics of gene expression, we performed cis…
CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised …
…, M Mendila, M Rashford, E Kuhnt, M Loeffler - The lancet …, 2006 - thelancet.com
… ; M Mendila organised the study, and discussed the report; M Rashford organised and
designed the study; E Kuhnt did statistical analyses and wrote the report; and M Loeffler designed …
designed the study; E Kuhnt did statistical analyses and wrote the report; and M Loeffler designed …
Molecular classification of diffuse cerebral WHO grade II/III gliomas using genome-and transcriptome-wide profiling improves stratification of prognostically distinct …
…, U Schlegel, B Radlwimmer, T Pietsch, M Loeffler… - Acta …, 2015 - Springer
Cerebral gliomas of World Health Organization (WHO) grade II and III represent a major
challenge in terms of histological classification and clinical management. Here, we asked …
challenge in terms of histological classification and clinical management. Here, we asked …
Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes
Diffuse large B cell lymphoma (DLBCL), the most common lymphoid malignancy in adults,
is a clinically and genetically heterogeneous disease that is further classified into …
is a clinically and genetically heterogeneous disease that is further classified into …
Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial …
…, N Schmitz, C Ruebe, AC Feller, M Loeffler - The lancet …, 2008 - thelancet.com
Background Cyclophosphamide, doxorubicin, vincristine, and prednisolone (CHOP) is used
to treat patients with non-Hodgkin lymphoma. Interval decrease from 3 weeks of treatment (…
to treat patients with non-Hodgkin lymphoma. Interval decrease from 3 weeks of treatment (…